Knowledge Center

Presentation / Sep 10, 2015

Screening methodologies to expedite the formulation development of amorphous solid dispersions

Authors:
  • Iris Duarte
  • Joao Henriques
  • Joao F. Pinto
  • Marcio Temtem
Source:
2015 APS Presentation, Íris Duarte

Related links

2015 APS Presentation - Screening methodologies

Also in the Knowledge Center

Related Content

Devices

Hovione offers simple, patented and globally competitive dry powder inhalers – Disposable, Capsule, Blister and Large Dose DPIs – which are available for fully integrated turn-key development with formulation and for licensing.

Page
Read more

Sunriser® DPI

High Performance, High-Dose Capsule DPI.

Page
Read more

Drug Product Development

Leveraging our expertise particle engineering, Hovione can now develop oral dosage forms and inhaled dosages forms to offer dependable solutions for complex drug products.

Page
Read more